HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$2.59
Day range
$2.59 - $2.85
Year range
$2.46 - $4.14
Market cap
234.49M USD
Avg Volume
467.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 35.60M | -44.22% |
Net income | -34.27M | 45.75% |
Net profit margin | — | — |
Earnings per share | -0.40 | 46.67% |
EBITDA | -38.94M | 44.14% |
Effective tax rate | -0.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 425.44M | -21.43% |
Total assets | 439.96M | -20.44% |
Total liabilities | 28.88M | -40.65% |
Total equity | 411.08M | — |
Shares outstanding | 85.58M | — |
Price to book | 0.54 | — |
Return on assets | -21.58% | — |
Return on capital | -22.88% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -34.27M | 45.75% |
Cash from operations | -30.56M | 23.33% |
Cash from investing | 85.61M | 50.71% |
Cash from financing | -347.00K | -331.33% |
Net change in cash | 54.70M | 220.11% |
Free cash flow | -14.85M | 12.32% |
About
Founded
2012
Headquarters
Website
Employees
56
